Sign in
4

Changes in Ownership

Lineage Cell Therapeutics, Inc. Filed Acc 0001209191-17-041267

Director bought 2,000 shares at $2.95 ($5,900)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
ANDREWS DEBORAH J Director 2017-06-16 Purchase +2,000 $2.95 $5,900 6,000 D: show line 1 in the form
Open-market purchases · 2,000 sh · avg $2.95 · $5,900
Loading xslF345X03/doc4.xml…